Effect of Sitagliptin on 24-Hour Glycemic Variations in Japanese Patients with Type 2 Diabetes as Assessed by Continuous Glucose Monitoring (CGM)

被引：0
|
作者：
Taniguchi, Yukiko
Mori, Yutaka
Matsuura, Kenichi
Itoh, Yohta
Sezaki, Kazunori
Yokoyama, Junichi
Tajima, Naoko
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A558 / A558
页数：1
相关论文
共 50 条
  • [41] Correlation between the indices for glycaemic variability and 24-hour urinary C-peptide values in patients with type 1 diabetes mellitus as assessed by CGM
    Seo, C.
    Nishimura, R.
    Onda, Y.
    Tsujino, D.
    Andou, K.
    Ustunomiya, K.
    DIABETOLOGIA, 2014, 57 : S214 - S214
  • [42] Effects of Dapagliflozin (DAPA), a Sodium Glucose Cotransporter 2 Inhibitor, on 24-Hour Glycemic Control in Patients with Type 2 Diabetes (T2D)
    Henry, Robert R.
    Strange, Poul
    Zhou, Rong
    Zhuplatov, Sergey B.
    Mansfield, Traci
    Klein, David
    Katz, Arie
    DIABETES, 2016, 65 : A311 - A311
  • [43] Continuous Glucose Monitoring (CGM) of Postprandial (PP) Glycemic esponses in Pregnancies Complicated by Diabetes
    Nosova, Emily V.
    Castorino, Kristin N.
    Levy, Carol J.
    Johnson, Terri
    Shah, Saloni
    Haroush, Gal
    Nelson, Kristen
    O'Malley, Grenye
    Ogyaadu, Selassie J.
    Levister, Camilla
    Brackett, Scott J.
    Polsky, Sarit
    DIABETES, 2020, 69
  • [44] Low-Carbohydrate Diet Did Not Affect the Behavior of Luseogliflozin, a Selective SGLT2 Inhibitor, on Glycemic Control over 24 Hours Measured by Continuous Glucose Monitoring (CGM) in Japanese Patients with Type 2 Diabetes
    Nishimura, Rimei
    Osonoi, Takeshi
    Jinnouchi, Hideaki
    Kanada, Shigeto
    Sakai, Soichi
    Samukawa, Yoshishige
    DIABETES, 2015, 64 : A240 - A240
  • [45] 24-hour blood pressure monitoring and renal function in patients with type 1 diabetes
    Korzeniewska-Dyl, Irmina
    Walczak, Konrad
    Baranski, Michal
    Szadkowska, Agnieszka
    Madej, Anna
    Moczulski, Dariusz
    CLINICAL DIABETOLOGY, 2015, 4 (03): : 91 - 97
  • [46] Correlation between glycemic trends assessed by 24 h continuous monitoring and autonomic activity in patients with recent onset type 2 diabetes
    Borgognoni, Laura
    Picciarella, Alice
    Di Stefano, Angelo
    Fontana, Vincenzo
    Russo, Alessandro
    Pascucci, Matteo
    Paris, Alberto
    Tubani, Luigi
    Fiorentini, Alessandra
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : E14 - E16
  • [47] Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus
    Koyanagawa, Naohide
    Miyoshi, Hideaki
    Ono, Kota
    Nakamura, Akinobu
    Cho, Kyu Yong
    Yamamoto, Kohei
    Takano, Yoshinari
    Dan-noura, Midori
    Atsumi, Tatsuya
    ENDOCRINE JOURNAL, 2016, 63 (08) : 747 - 753
  • [48] Sitagliptin, a DPP-4 inhibitor, administered once- or twice-daily, provides improvement throughout 24-hour glucose control in Japanese patients with type 2 diabetes mellitus
    Nonaka, K.
    Tsubouchi, H.
    Okuyama, K.
    Fukao, Y.
    Stein, P. P.
    DIABETOLOGIA, 2007, 50 : S365 - S366
  • [49] Glycemic Pattern in Diabetic Patients on Hemodialysis: Continuous Glucose Monitoring (CGM) Analysis
    Gai, Massimo
    Merlo, Ilenia
    Dellepiane, Sergio
    Cantaluppi, Vincenzo
    Leonardi, Gianluca
    Fop, Fabrizio
    Guarena, Cesare
    Grassi, Giorgio
    Biancone, Luigi
    BLOOD PURIFICATION, 2014, 38 (01) : 68 - 73
  • [50] Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Ying, Lingwen
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Zhou, Jian
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 753 - 759
12345